Esperion Therapeutics
ESPR
#6751
Rank
NZ$0.80 B
Marketcap
$4.10
Share price
-3.57%
Change (1 day)
154.38%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2023 (TTM): -$4.63

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.76. In 2022 the company made an earnings per share (EPS) of -$5.99 an increase over its 2021 EPS that were of -$16.13.

EPS history for Esperion Therapeutics from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.63-22.77%
2022-$5.99-62.87%
2021-$16.1380.38%
2020-$8.9450.14%
2019-$5.96-53.18%
2018-$12.727.41%
2017-$11.84110.81%
2016-$5.6247.35%
2015-$3.810.89%
2014-$3.7828.84%
2013-$2.93-89.3%
2012-$27.42
2002-$11.558.89%
2001-$10.61-83.77%
2000-$65.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$17.28 263.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.31-127.61%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.14-165.96%๐Ÿ‡บ๐Ÿ‡ธ USA
$63.03-1,424.82%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.08-77.30%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.15-75.89%๐Ÿ‡บ๐Ÿ‡ธ USA